date,title,source
Oct-17-18,Bristol-Myers Squibb to Showcase Immunoscience Research and Biomarker-Guided Treatment Approaches at the 2018 American College of Rheumatology and Association of Rheumatology Health Professionals Annual Meeting,Business Wire
Oct-19-18,Bristol-Myers Squibb Provides Update on the Ongoing Regulatory Review of Opdivo Plus Low-Dose Yervoy in First-Line Lung Cancer Patients with Tumor Mutational Burden 10 mut/Mb,Business Wire
Oct-19-18,BMY vs. LLY: Which Stock Should Value Investors Buy Now?,Zacks
Oct-19-18,"Today's Research Reports on Trending Tickers: Merck & Co., and Bristol-Myers Squibb",ACCESSWIRE
Oct-22-18,[$$] Bristol-Myers Faces a Costly Delay,The Wall Street Journal
Oct-22-18,Why Nektar Therapeutics Crashed 17.2% Today,Motley Fool
Oct-22-18,Mirati Shares Fall After Cancer Trial Progress Report,TheStreet.com
Oct-22-18,MarketPulse: Healthcare Slips as Bristol-Myers Squibb Sinks,Investing.com
Oct-22-18,Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy,TheStreet.com
Oct-22-18,"Dow Trades Lower After Momentum From China Rally Fades, Nasdaq Rises",TheStreet.com
Oct-22-18,Will Bristol-Myers move higher? Is Activision Blizzard ov...,CNBC Videos
Oct-22-18,[$$] Bristol-Myers Faces a Costly Delay,The Wall Street Journal
Oct-22-18,Why Mirati Therapeutics Inc. Is Plunging Today,Motley Fool
Oct-22-18,Mirati Therapeutics stock drops 19.5% after cancer trial results,MarketWatch
Oct-22-18,Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug,MarketWatch
Oct-22-18,Is a Beat in Store for Bristol-Myers (BMY) in Q3 Earnings?,Zacks
Oct-22-18,Are Bristol-Myers Squibb Companys (NYSE:BMY) Interest Costs Too High?,Simply Wall St.
Oct-22-18,Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Results in Significantly Longer Treatment-Free Survival in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma,Business Wire
Oct-22-18,Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Durable Four-Year Survival Benefits in Patients with Advanced Melanoma,Business Wire
Oct-22-18,Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Durable Clinical Benefit in Previously Untreated Patients with MSI-H or dMMR Metastatic Colorectal Cancer,Business Wire
Oct-23-18,"Bristol-Myers Declines, FDA Delays Review of Opdivo for NSCLC",Zacks
Oct-23-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers",Zacks
Oct-24-18,Bristol-Myers Squibb Q3 Earnings Outlook,Benzinga
Oct-24-18,"Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG",Zacks
Oct-25-18,Bristol-Myers Squibb Co (BMY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-25-18,"Pharma Giants Merck, Bristol Diverge On Earnings Beat As Sales Lag",Investor's Business Daily
Oct-25-18,Merck and Bristol-Myers Squibb Are Seeing Rising Sales of Their Cancer Drugs,Barrons.com
Oct-25-18,"Bristol-Myers (BMY) Beats on Q3 Earnings, Raises EPS View",Zacks
Oct-25-18,"Merck, Bristol-Myers profits rise on cancer drug sales",Reuters
Oct-25-18,"Bristol-Myers Beats Q3 Earnings, Boosts Full-Year Outlook on Solid Opdivo Sales",TheStreet.com
Oct-25-18,Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your Portfolio,Zacks
Oct-25-18,A Spotlight On Bristol-Myers Squibb Companys (NYSE:BMY) Fundamentals,Simply Wall St.
Oct-25-18,Bristol-Myers Squibb (BMY) Q3 Earnings Beat Estimates,Zacks
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-29-18,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Oct-29-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)",Zacks
Oct-30-18,Is Halloween the Best Time to Invest? 5 Solid Buys,Zacks
Oct-31-18,The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead,Zacks
Oct-31-18,"Zacks.com highlights: Bristol-Myers Squibb, United Rentals, Capital One Financial and Harris",Zacks
Oct-31-18,"The Zacks Analyst Blog Highlights: ArcBest, Express, Arch Coal, Bristol-Myers Squibb and Methanex",Zacks
Oct-31-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Bristol-Myers Squibb plans layoffs of ZymoGenetics' remaining Seattle-area employees,American City Business Journals
Nov-01-18,"Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales",Zacks
Nov-01-18,"Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View",Zacks
Nov-02-18,"AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues",Zacks
Nov-05-18,"Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates",Zacks
Nov-05-18,Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3,Zacks
Nov-05-18,"The Zacks Analyst Blog Highlights: Newfield Exploration, Amazon.com, Bristol-Myers Squibb, Eaton and CF Industries Holdings",Zacks
Nov-05-18,Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer,PR Newswire
Nov-07-18,"Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View",Zacks
Nov-07-18,"Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer",Zacks
Nov-07-18,Why Nektar Therapeutics Fell 36.5% in October,Motley Fool
Nov-07-18,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",Benzinga
Nov-07-18,Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference,Business Wire
Nov-08-18,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Nov-08-18,"Stada, Angelini among final bidders for $1 billion Bristol-Myers' UPSA unit - sources",Reuters
Nov-08-18,"Stada, Angelini among final bidders for $1 bln Bristol-Myers' UPSA unit - sources",Reuters
Nov-08-18,"Stada, Angelini among final bidders for $1 bln Bristol-Myers' Upsa unit - sources",Reuters
Nov-08-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-08-18,"Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise",Zacks
Nov-08-18,Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q3,Zacks
Nov-08-18,"Alnylam's (ALNY) Q3 Loss Narrower Than Expected, Sales Miss",Zacks
Nov-08-18,Democrats Hold Edge in House Battle: 5 Great Picks (Revised),Zacks
Nov-08-18,Wall Street Likely to Sustain Post-Midterm Rally: 5 Picks,Zacks
Nov-09-18,Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update,Zacks
Nov-09-18,"Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag",Zacks
Nov-09-18,Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018,Investor's Business Daily
Nov-09-18,"The Zacks Analyst Blog Highlights: DXP Enterprises, Bristol-Myers Squibb, EnPro Industries, Illumina and NetApp",Zacks
Nov-09-18,"Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",Zacks
Nov-09-18,Today's Research Reports on Trending Tickers: AstraZeneca and Bristol-Myers Squibb,ACCESSWIRE
Nov-12-18,Nektar Bounds Higher On 'Promising Contender' In Cancer Immunotherapy,Investor's Business Daily
Nov-12-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Bristol-Myers Squibb,ACCESSWIRE
Nov-13-18,"Bayer (BAYRY) Beats on Q3 Earnings, Revenue Estimates",Zacks
Nov-13-18,Today's Research Reports on Trending Tickers: Nektar Therapeutics and Bristol-Myers Squibb,ACCESSWIRE
Nov-14-18,Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know,Zacks
Nov-14-18,Can These 2 Battered Biotech Stocks Recover?,Motley Fool
Nov-14-18,Shire's Filing Accepted by FDA for Gattex's Label Expansion,Zacks
Nov-16-18,Bristol-Myers' Opdivo Receives Positive CHMP Opinion for RCC,Zacks
Nov-16-18,Is Paypal Holdings Inc (PYPL) A Good Investment Right Now?,Insider Monkey
Nov-16-18,"Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings",Zacks
Nov-16-18,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",Benzinga
Nov-19-18,"AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down",Zacks
Nov-20-18,Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know,Zacks
Nov-20-18,"Investor Expectations to Drive Momentum within Bristol-Myers Squibb, Leaf Group, SendGrid, Exantas Capital, Under Armour, and Medley Management  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-20-18,Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails,Zacks
Nov-20-18,Bristol-Myers Squibb to Take Part in Evercore ISI HealthCONx Conference,Business Wire
Nov-21-18,"Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility",Zacks
Nov-21-18,Shire-Takeda Deal Gets Phase I Conditional European Approval,Zacks
Nov-21-18,Is Bristol-Myers (BMY) a Great Stock for Value Investors?,Zacks
Nov-21-18,"Clovis' (CLVS) Rubraca Gets Another US Patent, Shares Up",Zacks
Nov-23-18,Bayer Hurts from Generic Competition & Pipeline Setbacks,Zacks
Nov-26-18,AMAG's Label Expansion of Lead Products Raises Share Price,Zacks
Nov-26-18,"After-hours buzz: AAPL, GM & more",CNBC
Nov-26-18,Bristol-Myers Squibb says cancer drug combination fails late-stage trial,Reuters
Nov-26-18,Bristol-Myers Squibb shares decline on failed lung-cancer drug study,MarketWatch
Nov-26-18,Bristol-Myers Squibb Announces CheckMate -451 Study Did Not Meet Primary Endpoint of Overall Survival with Opdivo Plus Yervoy Vs. Placebo as A Maintenance Therapy in Patients with Extensive-Stage Small Cell Lung Cancer After Completion of First-Line Chemotherapy,Business Wire
Nov-26-18,Glaxo Inks Marketing Deal for Anaemia Candidate in Japan,Zacks
Nov-26-18,"Bristol-Myers Squibb Awards Golden Tickets for LabCentral to ReviveMed, Strand Therapeutics",Business Wire
Nov-27-18,What Happened in the Stock Market Today,Motley Fool
Nov-27-18,Spirit Airlines jumps while United Technologies tumbles,Associated Press
Nov-27-18,US STOCKS-Wall St reverses losses after White House adviser's trade remarks,Reuters
Nov-27-18,"Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate",Zacks
Nov-27-18,Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial,Zacks
Nov-27-18,This Pharma Giant Is Still Consolidating Despite Lung Cancer Flop,Investor's Business Daily
Nov-27-18,Bristol-Myers Drops After Lung-Cancer Drug Study Fails,TheStreet.com
Nov-27-18,Glaxo (GSK) and J&J's HIV Drug Juluca Gets Approval in Japan,Zacks
Nov-27-18,"[$$] Stocks to Watch: Apple, GM, United Technologies",The Wall Street Journal
Nov-27-18,Dont Sell Bristol-Myers Squibb Company (NYSE:BMY) Before You Read This,Simply Wall St.
Nov-27-18,Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors,Zacks
Nov-27-18,"Stocks making the biggest move premarket: UTX, AAPL, HIBB, NVS, TSLA & more",CNBC
Nov-27-18,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",Benzinga
Nov-28-18,Bristol-Myers Squibb (BMY) Gains But Lags Market: What You Should Know,Zacks
Nov-28-18,Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity,Zacks
Nov-28-18,"Company News For Nov 28, 2018",Zacks
Nov-28-18,Todays Research Reports on Stocks to Watch: IntelliPharmaCeutics International and Bristol-Myers Squibb,ACCESSWIRE
Nov-29-18,Bristol-Myers Squibb to Highlight New Data from Broad Oncology Portfolio at the 60th American Society of Hematology Annual Meeting,Business Wire
Nov-29-18,Catalyst's Firdapse Receives FDA Approval for Rare Disease,Zacks
Nov-29-18,Bristol-Myers Squibb to Take Part in Citi 2018 Global Healthcare Conference,Business Wire
Nov-30-18,Novartis' Gilenya Approved in EU for Expanded Population,Zacks
Nov-30-18,Lilly (LLY) Hits Fresh High: Is There Still Room to Run?,Zacks
Nov-30-18,Bayer (BAYRY) to Restructure Business & Reduce Headcount,Zacks
Dec-03-18,Bristol-Myers Squibb to Transfer $3.8 billion in U.S. Pension Liabilities,Business Wire
Dec-03-18,Shire's Takhzyro Gets European Nod for Hereditary Angioedema,Zacks
Dec-03-18,5 Best Stocks to Own This December,Zacks
Dec-04-18,J&J Strikes Deal with argenx to Co-Develop Cancer Antibody,Zacks
Dec-04-18,Roche Announces Positive Data on Venclexta/Venclyxto at ASH,Zacks
Dec-04-18,"The Zacks Analyst Blog Highlights: Shoe Carnival, On Deck, DXP, Arch Coal and Bristol-Myers",Zacks
Dec-06-18,Bristol-Myers Squibb Announces Dividend Increase,Business Wire
Dec-06-18,Bristol-Myers Stock Is Rising on an Analyst Upgrade,Barrons.com
Dec-07-18,Bristol-Myers Squibb (BMY) Stock Moves -0.32%: What You Should Know,Zacks
Dec-07-18,CEO of Chapel Hill firm talks 2 new partnerships with big pharma,American City Business Journals
Dec-07-18,Mallinckrodt (MNK) to Separate Generics & Branded Businesses,Zacks
Dec-07-18,"The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut",Benzinga
Dec-07-18,Hedge Funds Are Betting On Bristol Myers Squibb Co. (BMY),Insider Monkey
Dec-10-18,Roche's Tecentriq Gets FDA Approval for First-Line NSCLC,Zacks
Dec-10-18,Today's Research Reports on Trending Tickers: Johnson & Johnson and Bristol-Myers Squibb,ACCESSWIRE
Dec-10-18,Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers,Business Wire
Dec-11-18,5 Companies That Raised Dividends as Bond Yields Increase,Barrons.com
Dec-11-18,Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800,Zacks
Dec-12-18,Roche to Create Companion Diagnostic Test for Merck's Keytruda,Zacks
Dec-12-18,Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan,Zacks
Dec-13-18,Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know,Zacks
Dec-13-18,J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study,Zacks
Dec-13-18,Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA,Zacks
Dec-13-18,Are You Overlooking This High-Growth Industry During Corrections and Recessions?,Motley Fool
Dec-13-18,Upgraded Broker Ratings Make These 5 Stocks Worth a Look Now,Zacks
Dec-14-18,"Your first trade for Friday, December 14",CNBC
Dec-14-18,"Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus",Zacks
Dec-14-18,"Zacks.com featured highlights include: Nexstar Media, Bristol-Myers Squibb, Capital One Financial, Helmerich & Payne and Progressive",Zacks
Dec-14-18,Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Novartis,ACCESSWIRE
Dec-17-18,Pfizer's (PFE) Biosimilar of Avastin Gets Positive CHMP Nod,Zacks
Dec-17-18,Bristol-Myers Squibb and Boston Medical Center Announce Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance,Business Wire
Dec-17-18,Merck to Acquire Europe's Antelliq Group for $2.4 Billion,Zacks
Dec-17-18,Lilly (LLY) to Acquire Pain Candidate From Private Biotech,Zacks
Dec-17-18,"The Zacks Analyst Blog Highlights: Comcast, American Express, Bristol-Myers, T-Mobile and General Motors",Zacks
Dec-17-18,Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Sprycel (dasatinib) for Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia,Business Wire
Dec-17-18,Bristol-Myers Squibb and H3 Biomedicine Announce Research Collaboration to Advance Novel Therapeutics Leveraging H3s RNA Splicing Platform,Business Wire
Dec-17-18,Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA - Bloomberg,Reuters
Dec-17-18,Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg,Reuters
Dec-18-18,Merck's Keytruda Gets EU Nod as Adjuvant Therapy for Melanoma,Zacks
Dec-18-18,BMY vs. AZN: Which Stock Should Value Investors Buy Now?,Zacks
Dec-19-18,Bristol-Myers gets $1.6 billion offer for French consumer health unit,Reuters
Dec-19-18,Bristol-Myers gets $1.6 billion offer for French consumer health unit,Reuters
Dec-19-18,[$$] Bristol-Myers to Sell French Unit to Japan's Taisho for $1.6B,The Wall Street Journal
Dec-19-18,"Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical Holdings Co., Ltd to Purchase UPSA",Business Wire
Dec-20-18,Merck's Keytruda Gets FDA Approval for Rare Skin Cancer,Zacks
Dec-20-18,Who Has Been Buying Bristol-Myers Squibb Company (NYSE:BMY) Shares?,Simply Wall St.
Dec-20-18,Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Mylan,ACCESSWIRE
Dec-21-18,"Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations",Zacks
Dec-24-18,Pfizer/Merck KGaA End Bavencio Ovarian Cancer Phase III Study,Zacks
Dec-26-18,Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?,Investor's Business Daily
Dec-26-18,"Bristol-Myers Squibb Stock Is Coming Back Slow, but Thats Fine",InvestorPlace
Dec-26-18,Bayer (BAYRY) Faces Generic Threat & Rising Competition,Zacks
Dec-26-18,AbbVie Partners Lupin to Boost Hematological Cancer Pipeline,Zacks
Dec-27-18,Alexion's (ALXN) Soliris Drives Growth Amid Pricing Pressure,Zacks
Dec-27-18,Immunomedics Enters Into Supply Deal for Breast Cancer Drug,Zacks
Dec-27-18,Sanofi Wins FDA Nod for Pediatric Hexavalent Combo Vaccine,Zacks
Dec-28-18,Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know,Zacks
Dec-28-18,BioXcel Surges on Fast Track Designation to Agitation Drug,Zacks
Dec-31-18,Novartis (NVS) Benefits From New Drugs & Key Acquisitions,Zacks
Dec-31-18,Better Buy: Celgene vs. Bristol-Myers Squibb,Motley Fool
Dec-31-18,"Report: Exploring Fundamental Drivers Behind Bristol-Myers Squibb, Ascena Retail Group, OrthoPediatrics, Star Bulk Carriers, Leidos, and ADOMANI  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Jan-02-19,Biopharmas Restrained In Drug Pricing For 2019  With These Exceptions,Investor's Business Daily
Jan-02-19,Horizon Pharma (HZNP) Up 28% on Business Expansion Strategy,Zacks
Jan-03-19,Cramer Remix: The monumental deal you might've missed,CNBC
Jan-03-19,Bristol-Myers Squibb buying Celgene in $74B deal,Associated Press
Jan-03-19,"Biotechs build buzz, rack up deals ahead of big JPM conference",American City Business Journals
Jan-03-19,Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal,Reuters
Jan-03-19,Celgene Corporation -- Moody's reviews Celgene's Baa2 rating for upgrade,Moody's
Jan-03-19,Factbox: Bristol-Myers' $74 billion Celgene buy has investors looking for next deal,Reuters
Jan-03-19,Bristol-Myers Loan for Celgene to Rank Among Top 10 Ever,Bloomberg
Jan-03-19,Heres What Celgene Shareholders Are Getting From Bristol-Myers Squibb,Motley Fool
Jan-03-19,Dow Tumbles 660 Points Because It Could Go Either Way,Barrons.com
Jan-03-19,What Happened in the Stock Market Today,Motley Fool
Jan-03-19,"3 Things to Know at Market Close: Apple, Bristol-Myers and the Jobs Report",TheStreet.com
Jan-03-19,Father and son advised on opposite sides of Bristol-Celgene deal,Reuters
Jan-03-19,"Dow Drops More Than 600 Points on Apple Warning, China Fears",TheStreet.com
Jan-03-19,Bristol-Myers Squibb Tabs Cancer Drug Specialist Celgene in $74 Billion Takeover,TheStreet.com
Jan-03-19,Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid,Investor's Business Daily
Jan-03-19,P.R. Ind Tour Ed Med & Env Ctl Facs Fin Auth -- Moody's reviews Bristol-Myers Squibb for downgrade,Moody's
Jan-03-19,Wall Street Retreats Thursday,GuruFocus.com
Jan-03-19,Bristol-Myers Squibb Rings in the New Year by Buying Celgene for $74 Billion,GuruFocus.com
Jan-03-19,Jim Cramer: The Long-Awaited Drug Company Consolidation Has Begun,TheStreet.com
Jan-03-19,Gilead Stock Breaks Out to Channel Resistance,Investopedia
Jan-03-19,Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies,CNBC
Jan-03-19,Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene,ETF Trends
Jan-03-19,[$$] Bristol-Myers and Celgene: Side Effects Will Be Temporary,The Wall Street Journal
Jan-03-19,Cost to insure Bristol-Myers debt jumps as leverage balloons,Reuters
Jan-03-19,Bears On Track To End Nasdaq's Five-Day Win Streak,Investor's Business Daily
Jan-03-19,Cost to insure Bristol-Myers debt jumps as leverage balloons,Reuters
Jan-03-19,The Celgene Deal Shows How the Lines Between Biotech and Big Pharma Have Blurred,Barrons.com
Jan-03-19,Bristol-Myers bulks up with $74 billion deal to buy Celgene,Reuters
Jan-03-19,Bristol-Myers buys Celgene for $74 billion,Reuters Videos
Jan-03-19,Bristol-Myers to Buy Celgene in $74 Billion Cancer-Drug Bet,Bloomberg
Jan-03-19,[$$] Bristol-Myers Squibb to Acquire Celgene for About $74 Billion,The Wall Street Journal
Jan-03-19,"Stock Market News: Dow Jones Slumps On Apple Warning, Weak ISM Data",Investor's Business Daily
Jan-03-19,Celgene Surges as Bristol-Myers Squibb Blockbuster Deal Begins Year With a Bang,TheStreet.com
Jan-03-19,Is Bristol-Myers Paying Too Much for Celgene?,TheStreet.com
Jan-03-19,Bristol-Myers Squibb to acquire New Jersey biotech company in $74B deal,American City Business Journals
Jan-03-19,Celgene Stock Is Soaring After Bristol-Myers Squibb Made an Offer to Buy It. Investors Should Get Out Now.,Barrons.com
Jan-03-19,Here's Why BeiGene Is Taking a Hit Today,Motley Fool
Jan-03-19,Gilead Sciences Gets a Boost After Celgene Deal,Barrons.com
Jan-03-19,Celgene's bonds rally sharply on news of Bristol-Myers takeover,MarketWatch
Jan-03-19,Dow Tumbles More Than 550 Points; Apple Sells Off On Slashed Estimates,Investor's Business Daily
Jan-03-19,"Big News Day: Apple, New Jobs, Celgene & More",Zacks
Jan-03-19,Bristol-Myers Squibb Is Buying Celgene in a $74 Billion Deal,Barrons.com
Jan-03-19,"Jim Cramer: Bristol-Myers, Apple, and the Markets",TheStreet.com
Jan-03-19,Celgene (CELG) Alert: Johnson Fistel Investigates Proposed Sale of Celgene Corporation; Are Celgene Shareholders Getting a Fair Deal?,PR Newswire
Jan-03-19,Bristol-Myers Finds a $74 Billion Biotech Bargain,Bloomberg
Jan-03-19,Why Celgene's Stock Is On Fire and Bristol-Myers Squibb's Is Sinking Today,Motley Fool
Jan-03-19,"Celgene shareholders should sell now, Leerink says",MarketWatch
Jan-03-19,Bristol-Myer sets 2019 adjusted EPS guidance that tops estimates,MarketWatch
Jan-03-19,Bristol-Myers Squibb to acquire Celgene for $74B,Fox Business Videos
Jan-03-19,Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion,Associated Press
Jan-03-19,Bristol-Myers to acquire Celgene in cash-and-stock deal with equity value of about $74 billion,MarketWatch
Jan-03-19,Bristol-Myers to buy Celgene in $74B deal,CNBC Videos
Jan-03-19,Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company,Business Wire
Jan-04-19,AbbVie (ABBV) Inks Immunotherapy Deal with Private Biotech,Zacks
Jan-04-19,"Johns Hopkins, Bristol-Myers must face $1 bln syphilis infections suit",Reuters
Jan-04-19,Bristol To Become Top 5 Pharma  And Other Fallout From Celgene Takeover,Investor's Business Daily
Jan-04-19,"Stock Market Rally Extends On Fed Chairman Powell, Jobs; Apple, Tesla, Delta Disappoint; Bristol-Myers Buys Celgene: Weekly Review",Investor's Business Daily
Jan-04-19,Candel Therapeutics Completes $28.7 Million Series B Financing,GlobeNewswire
Jan-04-19,"Manufacturing, Apple, & Jobs: This Week's Top Market Stories",Zacks
Jan-04-19,"Johns Hopkins, Bristol-Myers must face $1 bln syphilis infections lawsuit",Reuters
Jan-04-19,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Celgene Corporation to Bristol-Myers Squibb Company is Fair to Shareholders",GlobeNewswire
Jan-04-19,Flex Pharma Finds A Lifeline In Merger With Oncology Biotech Salarius Pharma,Benzinga
Jan-04-19,Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout,InvestorPlace
Jan-04-19,"Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate",Zacks
Jan-04-19,Trump's FDA may greenlight drug-prescribing apps: Report,Fox Business Videos
Jan-04-19,"Company News For Jan 4, 2019",Zacks
Jan-04-19,Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus,Zacks
Jan-04-19,"Celgene, Bristol-Myers set $2.2 billion termination fee for their mega deal",Reuters
Jan-04-19,Bristol-Myers to Acquire Leading Biotech Celgene for $74B,Zacks
Jan-04-19,"Celgene, Bristol-Myers set $2.2 billion termination fee for their mega deal",Reuters
Jan-04-19,Should Celgene Investors Take Bristol's Money and Run?,Motley Fool
Jan-04-19,Heres What Bristol-Myers Squibb Will Look Like After Acquiring Celgene,Motley Fool
Jan-04-19,[$$] The Muscle Morgan Stanley Flexed in the $74 Billion Bristol-Myers Deal,The Wall Street Journal
Jan-04-19,Today's Research Reports on Trending Tickers: Pfizer and Bristol-Myers Squibb,ACCESSWIRE
Jan-04-19,PRESS DIGEST -Wall Street Journal - Jan 4,Reuters
Jan-07-19,"Biotech's big conference living up to reputation with big deals, big costs",American City Business Journals
Jan-07-19,Soon-Shiongs NantCell gets $30 million from Celgene,American City Business Journals
Jan-07-19,Celgene Expects to Generate Up to $17.2 Billion in Revenue in 2019,TheStreet.com
Jan-07-19,5 Top-Selling Drugs With Growth Potential In 2019,Benzinga
Jan-07-19,Big Pharma Isn't Boring Any More as Cancer Deals Herald More M&A,Bloomberg
Jan-07-19,Bristol-Myers and Celgene CEOs talk acquisition deal,CNBC Videos
Jan-07-19,Celgene provides 2019 profit and sales outlooks above expectations,MarketWatch
Jan-07-19,5 Things to Watch for at the JPMorgan Healthcare Conference,Investopedia
Jan-07-19,"The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie",Zacks
Jan-07-19,"Tough Days for Giants Apple, Bristol-Myers",Motley Fool
Jan-07-19,Should Investors Like Bristol-Myers' Buyout of Celgene?,Motley Fool
Jan-08-19,The 10 Best Health-Care Stocks to Buy for 2019,Kiplinger
Jan-08-19,"CELGENE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Celgene Corporation - CELG",PR Newswire
Jan-08-19,Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo,Zacks
Jan-08-19,Crowded Cancer Space Triggers Big M&A Deals: More in Store?,Zacks
Jan-08-19,4 Biotechs That Are Potential Buyouts Post Celgene Deal,Zacks
Jan-08-19,Debt Buybacks Could Be The New Stock Buybacks,Barrons.com
Jan-08-19,BMS/ Celgene Deal Could Spark M/A Activity,ACCESSWIRE
Jan-09-19,"The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo",Zacks
Jan-09-19,3 Reasons Buying Celgene Right Now Makes Sense,Motley Fool
Jan-10-19,Ex-Juno executives reportedly seeking up to $1 billion for new Seattle startup,American City Business Journals
Jan-10-19,Will Pfizer Join The Buying Spree With This Small Biotech Stock?,Investor's Business Daily
Jan-10-19,3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year,Motley Fool
Jan-10-19,Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting,Zacks
Jan-11-19,"Lilly eyes more cancer deals, but wary of CAR-T, gene therapy",Reuters
Jan-11-19,Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference,CNBC
Jan-11-19,The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock,InvestorPlace
Jan-11-19,Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer,Zacks
Jan-11-19,Healthcare deals raise pulse of US lending in 2019,Reuters
Jan-11-19,3 Biotech Stocks Bubbling Away,Investopedia
Jan-11-19,4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019,Zacks
Jan-14-19,5 Reasons Why Investors Should Buy Exelixis (EXEL) in 2019,Zacks
Jan-14-19,Bristol-Myers Squibb (BMY) Stock Moves -0.04%: What You Should Know,Zacks
Jan-14-19,European Commission Approves Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) for First-Line Treatment of Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma,Business Wire
Jan-14-19,The Gold Rush of 2019,TheStreet.com
Jan-15-19,Peninsula biotech sheds 20% of jobs to focus on drugs closer to finish line,American City Business Journals
Jan-15-19,Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter,Investor's Business Daily
Jan-15-19,Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer,Zacks
Jan-15-19,How an East Bay cancer fighter  once kicked to the curb by Big Pharma  picked up its 4th drug approval,American City Business Journals
Jan-15-19,Exelixis' Cabometyx Tablets Receive FDA Nod for Liver Cancer,Zacks
Jan-16-19,Ligand Crashes To Nearly 2-Year Low After Short-Seller Bashes It,Investor's Business Daily
Jan-16-19,"Takeda Wraps Its Shire Buyout, CEO Sees More Mergers Coming",Investor's Business Daily
Jan-16-19,"Top Analyst Reports for Procter & Gamble, NVIDIA & Bristol-Myers",Zacks
Jan-17-19,1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet),Motley Fool
Jan-17-19,The Stable Value Stock Is Built to Weather Market Storms,GuruFocus.com
Jan-17-19,What Kind Of Investor Owns Most Of Bristol-Myers Squibb Company (NYSE:BMY)?,Simply Wall St.
Jan-17-19,Ligand (LGND) Takes a Hit on Citron's Negative Research Report,Zacks
Jan-17-19,Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth,Zacks
Jan-17-19,Why Bristol-Myers Squibb Stock Sank By 15.2% in 2018,Motley Fool
Jan-17-19,"The Zacks Analyst Blog Highlights: Procter &amp; Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab",Zacks
Jan-17-19,Citron Says Ligand Has 80% Downside in Explosive Note,Investopedia
Jan-18-19,"Cramer's game plan: This week, forecasts are more important than earnings",CNBC
Jan-18-19,"Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY",Zacks
Jan-18-19,"Ahead of Bristol Myers purchase, Celgene partners with Boston cancer startup",American City Business Journals
Jan-22-19,Here's How John Paulson Is Positioning His Celgene/Bristol Trade,Bloomberg
Jan-22-19,All Signals Are Positive for Buying Abbott Laboratories,InvestorPlace
Jan-22-19,"Stanley Black & Decker, J&J Fall as Growth Worries Hit Stocks",Barrons.com
Jan-23-19,Bristol-Myers Squibb Q4 Earnings Preview,Benzinga
Jan-23-19,Mario Gabelli answers your questions,CNBC Videos
Jan-23-19,Day Ahead: Top 3 Things to Watch,Investing.com
Jan-23-19,5 Best Biotech Bets Likely to Outperform Estimates in Q4,Zacks
Jan-24-19,What Happened in the Stock Market Today,Motley Fool
Jan-24-19,[$$] Bristol-Myers Reports Higher Sales but Another Lung-Cancer Setback,The Wall Street Journal
Jan-24-19,"Bristol-Myers Tops Q4 Earnings, Pulls FDA Application for Cancer Combination",TheStreet.com
Jan-24-19,Bristol-Myers Dips On Cancer Stumble Despite Quarterly Beat,Investor's Business Daily
Jan-24-19,Dow Stumbles on Conflicting Signals Over U.S.-China Trade Talks,TheStreet.com
Jan-24-19,What's Behind the Biotech ETF Rally to Start 2019?,Zacks
Jan-24-19,Bristol-Myers has Opdivo lung cancer setback as sales beat estimates,Reuters
Jan-24-19,Bristol-Myers has Opdivo lung cancer setback as sales beat estimates,Reuters
Jan-24-19,Stronger Than Expected Earnings from Bristol,Morningstar
Jan-24-19,"Bristol-Myers (BMY) Beats Q4 Earnings, Withdraws Opdivo sBLA",Zacks
Jan-24-19,"Bristol-Myers, Celgene deal in focus",CNBC Videos
Jan-24-19,"Italy drugmaker Zambon ready to splash out in U.S., China push",Reuters
Jan-24-19,Bristol-Myers Shares Slide as Cancer-Drug Race Intensifies,Bloomberg
Jan-24-19,Heres Why Bristol-Myers Needs a $74 Billion Shot in the Arm,Bloomberg
Jan-24-19,Bristol-Myers Squibb Withdraws Regulatory Application For Lung Cancer Combo Drug,Benzinga
Jan-24-19,Bristol-Myers shares fall after it withdraws FDA application for combo lung cancer treatment,CNBC
Jan-24-19,US Futures Edge Higher on Mixed Earnings; Growth and Trade Concerns Linger,TheStreet.com
Jan-24-19,Bristol-Myers: 4Q Earnings Snapshot,Associated Press
Jan-24-19,Bristol-Myers pulls U.S. application for combo lung cancer treatment,Reuters
Jan-24-19,Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results,Business Wire
Jan-24-19,Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call,Business Wire
Jan-24-19,"Global Stocks Stall Amid Growth, Trade Concerns; Wall Street Futures Mixed",TheStreet.com
Jan-24-19,"Bristol-Myers Squibb Earnings, Revenue beat in Q4",Investing.com
Jan-25-19,Edited Transcript of BMY earnings conference call or presentation 24-Jan-19 1:30pm GMT,Thomson Reuters StreetEvents
Jan-25-19,US companies turning to term loans for acquisition debt,Reuters
Jan-25-19,Celgene Stock Is Rising After the CEO of AbbVie Ruled Out a Big Deal,Barrons.com
Jan-25-19,"Pharma Stock Roundup: JNJ &amp; BMY's Q4 Earnings, Study Failures at LLY &amp; ABBV",Zacks
Jan-25-19,AbbVie not contemplating big deals - CEO,Reuters
Jan-25-19,Are You Looking for a High-Growth Dividend Stock? Bristol-Myers Squibb (BMY) Could Be a Great Choice,Zacks
Jan-25-19,Morning Earnings Recap: The Biggest Reports From Thursday's Session,Benzinga
Jan-28-19,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Jan-28-19,Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth,Zacks
Jan-28-19,Pfizer Stock Is at Do-or-Die Spot Ahead of Earnings,InvestorPlace
Jan-28-19,"Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB &amp; AGN",Zacks
Jan-28-19,"The Zacks Analyst Blog Highlights: J&amp;J, Bristol-Myers, Lilly, AbbVie and Merck",Zacks
Jan-28-19,Climate Change Could Hit These Companies Hardest,Barrons.com
Jan-29-19,"Allergan (AGN) Q4 Earnings Beat Estimates, 2019 View Tepid",Zacks
Jan-29-19,Is a Beat in the Cards for Celgene (CELG) in Q4 Earnings?,Zacks
Jan-30-19,Novartis 2019 growth outlook leaves investors wanting more,Reuters
Jan-31-19,Celgene Corporation (CELG) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Jan-31-19,"The Eaton Vance Fund Exits Aetna, Bristol Myers",GuruFocus.com
Jan-31-19,"Celgene (CELG) Q4 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Jan-31-19,Celgene profit beats as psoriasis drug sales surge,Reuters
Jan-31-19,Celgene stock up 0.4% after earnings beat,MarketWatch
Jan-31-19,Celgene posts 16 pct rise in fourth quarter revenue,Reuters
Feb-01-19,"Novo Nordisk (NVO) Q4 Earnings Miss Estimates, Revenues Beat",Zacks
Feb-01-19,Merck Pops On Quarterly Beat As Keytruda Sales Jump Despite U.S. Lag,Investor's Business Daily
Feb-01-19,Pharma Catches Another Case Of M&A Fever,Benzinga
Feb-01-19,AVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDA,Zacks
Feb-01-19,Top Ranked Income Stocks to Buy for February 1st,Zacks
Feb-01-19,Merck Stock Gains Because Cancer Drug Brings Rising Earnings,Barrons.com
Feb-01-19,"Lilly (LLY) Hits 52-Week High, Can the Run Continue?",Zacks
Feb-04-19,Here's Why Mirati Therapeutics Jumped 55.8% in January,Motley Fool
Feb-04-19,Stocks Rise Ahead of Alphabet Earnings,TheStreet.com
Feb-04-19,Report Says Starboard Value Takes Stake in Bristol-Myers,TheStreet.com
Feb-04-19,"Papa John's Stock Surges As Starboard Invests $200 Million, CEO Becomes Chairman",Investor's Business Daily
Feb-04-19,"An activity targets BMY, GM looks to Brazil & more",CNBC Videos
Feb-04-19,Celgene Highlights What Bristol-Myers Squibb Is Getting,Motley Fool
Feb-04-19,Bristol-Myers Gains After Starboard Takes a Position,Bloomberg
Feb-04-19,Heres What Starboard Might Be Planning for Papa Johns and Bristol-Myers,Barrons.com
Feb-04-19,Faber: Hedge fund Starboard Value has not contacted Bristol-Myers Squibb,CNBC Videos
Feb-05-19,Merck CEO Frazier to testify at Senate drug pricing hearing,Reuters
Feb-05-19,CEO of activist hedge fund Starboard: 'We are certainly interested in the story at Bristol-Myers',CNBC Videos
Feb-05-19,CEO of activist hedge fund Starboard: 'We are certainly interested in the story at Bristol-Myers',CNBC
Feb-05-19,"Pharma execs will testify before Congress 'one way or another,' US senator says",CNBC
Feb-05-19,"There's 'no doubt' Papa John's needs to get better, says CEO",CNBC Videos
Feb-05-19,5 Stocks With Strong Sales Growth Worth Buying Right Now,Zacks
Feb-05-19,&quot;Business is Booming&quot; at Bristol-Myers,MoneyShow
Feb-06-19,At least four pharma CEOs to testify at Senate drug pricing hearing,Reuters
Feb-06-19,Bristol-Myers Stock Could Get Hit By Donald Trumps Drug-Price Plan,Barrons.com
Feb-06-19,At least four pharma CEOs to testify at Senate drug pricing hearing,Reuters
Feb-06-19,"Zacks.com featured highlights include: Starbucks, Bristol-Myers, Portland General Electric, Foot Locker and J.B. Hunt",Zacks
Feb-06-19,Kaskela Law LLC Announces Stockholder Investigation of Bristol-Myers Squibb Company - BMY,ACCESSWIRE
Feb-06-19,10 Industries That Haven't Been This Cheap in at Least 5 Years,Motley Fool
Feb-06-19,"Boasting A 36% Return On Equity, Is Bristol-Myers Squibb Company (NYSE:BMY) A Top Quality Stock?",Simply Wall St.
Feb-06-19,Winners &amp; Losers from Trump's State of the Union Address,Zacks
Feb-07-19,Exelixis (EXEL) to Report Q4 Earnings: What's in Store?,Zacks
Feb-07-19,Bristol-Myers Squibb to Take Part in Guggenheim Healthcare Talks Idea Forum,Business Wire
Feb-08-19,Alnylam's (ALNY) Q4 Earnings and Revenues Beat Estimates,Zacks
Feb-11-19,Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma,Business Wire
Feb-11-19,"Top Analyst Reports for Bristol-Myers, ConocoPhillips & Qualcomm",Zacks
Feb-11-19,This is Why Bristol-Myers Squibb (BMY) is a Great Dividend Stock,Zacks
Feb-11-19,3 Reasons Growth Investors Will Love Bristol-Myers (BMY),Zacks
Feb-11-19,"IFM Therapeutics launches new spinout aimed at Parkinson's, lupus and other diseases",American City Business Journals
Feb-11-19,European Commission Approves Bristol-Myers Squibbs Sprycel (dasatinib) in Combination with Chemotherapy for Treatment of Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia,Business Wire
Feb-11-19,"Big Pharma Wants to Borrow Cash for M&A, but Could Run Into Credit Downgrades",Barrons.com
Feb-12-19,Bristol-Myers' Sprycel Gets European Nod for Label Expansion,Zacks
Feb-12-19,Seattle Genetics' Adcetris Gets EC Nod for Label Expansion,Zacks
Feb-12-19,Pfizer sBLA for Kidney Cancer Drug Combo Gets Priority Review,Zacks
Feb-12-19,AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma,Zacks
Feb-12-19,"The Zacks Analyst Blog Highlights: Bristol-Myers, ConocoPhillips, Qualcomm, General Motors and Marathon",Zacks
Feb-12-19,"The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",Benzinga
Feb-13-19,Exelixis Grabs 90% of First Place,Motley Fool
Feb-13-19,AEMD: Eventual FDA Cancer Indication Is A Realistic Outcome,Zacks Small Cap Research
Feb-13-19,"Exelixis (EXEL) Earnings, Revenues Beat Estimates in Q4",Zacks
Feb-13-19,Celgene vs. Gilead Stock: Whats the Better Biotech Buy?,InvestorPlace
Feb-13-19,J&amp;J's (JNJ) Depression Treatment Gets FDA Committee's Nod,Zacks
Feb-13-19,5 Tiny Biotech Stocks With Superb Growth Potential,Zacks
Feb-14-19,Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer,Business Wire
Feb-14-19,Johnson &amp; Johnson (JNJ) to Acquire Auris Health for $3.4B,Zacks
Feb-14-19,"Zoetis (ZTS) Beats on Q4 Earnings &amp; Sales, Shares Up",Zacks
Feb-14-19,5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings,Zacks
Feb-14-19,Should You Buy Viking Therapeutics After Gilead Drug Failure?,InvestorPlace
Feb-14-19,BMY vs. AZN: Which Stock Is the Better Value Option?,Zacks
Feb-14-19,"AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales",Zacks
Feb-15-19,Bristol-Myers Squibb Company -- Moody's announces completion of a periodic review of ratings of Bristol-Myers Squibb Company,Moody's
Feb-15-19,"Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients",Reuters
Feb-15-19,"Prothena's (PRTA) Q4 Earnings Beat, Revenues Miss Estimates",Zacks
Feb-15-19,"Fridays Vital Data: Bristol-Myers Squibb, Intel and Activision Blizzard",InvestorPlace
Feb-15-19,Strength Seen in AstraZeneca (AZN): Stock Soars 9.3%,Zacks
Feb-19-19,How to Replicate Hedge Fund Strategies with ETFs,Zacks
Feb-19-19,Bayer Obtains Full Rights to Vitrakvi From Lilly's Loxo,Zacks
Feb-20-19,Investor Starboard Unhappy With Bristol-Myers' Deal to Buy Celgene,The Wall Street Journal
Feb-20-19,"Bristol-Myers says Starboard nominated five directors, bought shares",Reuters
Feb-20-19,"Bristol-Myers says Starboard nominated five directors, bought shares",Reuters
Feb-20-19,"Starboard Value has 1 million-share stake in Bristol-Myers Squibb, has met with management",CNBC
Feb-20-19,"Bristol-Myers says Starboard nominated five directors, bought shares",Reuters
Feb-20-19,Activist hedge fund Starboard nominates five directors to Bristol-Myers board,CNBC Videos
Feb-20-19,"Bristol-Myers says Starboard nominated five directors, bought shares",Reuters
Feb-20-19,Novo Nordisk Gets FDA Nod for Haemophilia Drug Esperoct,Zacks
Feb-20-19,Bristol-Myers Squibb Provides Update on Pending Transaction with Celgene,Business Wire
Feb-20-19,Merck Shares Drop After Keytruda Treatment Fails Late-Stage Liver Cancer Trial,TheStreet.com
Feb-21-19,US corporates tap term loans as they look to avert downgrades,Reuters
Feb-21-19,"Bausch (BHC) Q4 Earnings Beat Estimates, Revenues Down Y/Y",Zacks
Feb-21-19,Merck To Buy Immune Design For $300M,Benzinga
Feb-21-19,PRESS DIGEST -Wall Street Journal - Feb 21,Reuters
Feb-22-19,Merck to Buy Immunotherapy Developer Immune Design for $300M,Zacks
Feb-22-19,Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with Proposed Merger with Celgene,Business Wire
Feb-25-19,Technician says it's time to fade the biotech rally,CNBC Videos
Feb-25-19,"Bristol-Myers Squibb Company (BMY) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Feb-25-19,Drugmakers CEOs set to get grilled at Senate hearing on rising drug prices,MarketWatch
Feb-25-19,Factbox: Pharma company executives to testify at U.S. Senate drug price hearing,Reuters
Feb-25-19,Scott Black's Top 5 New Buys for the 4th Quarter,GuruFocus.com
Feb-25-19,"For Two Huge Deals, Arbitrage Goes Out the Window",Bloomberg
Feb-25-19,What's in the Cards for Nektar (NKTR) This Earnings Season?,Zacks
Feb-26-19,"Bristol-Myers Squibb Company (BMY) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Feb-26-19,Lawmakers grill top pharma execs over high drug costs,CNBC Videos
Feb-26-19,Big Pharma trims projects  and a potential $1 billion in payments  from collaboration with small Peninsula biotech,American City Business Journals
Feb-26-19,Drugmakers CEOs clash with senators in hearing on drug price hikes,MarketWatch
Feb-26-19,Senators say will support Judiciary panel if it looks into drug patents,Reuters
Feb-26-19,Pharma execs offer Senate ideas to lower drug costs  except actually cutting prices,CNBC
Feb-26-19,Drugmakers CEOs set to get grilled at Senate hearing on rising drug prices,MarketWatch
Feb-26-19,"[$$] Stocks to Watch: Tesla, Macy's, Bristol-Myers Squibb, and Shake Shack",The Wall Street Journal
Feb-26-19,Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakers,CNBC
Feb-26-19,Bristol-Myers Squibb Company (NYSE:BMY): What Are The Future Prospects?,Simply Wall St.
Feb-26-19,Another San Antonio biotech changing its name and CEO,American City Business Journals
Feb-27-19,Celgene stock falls 8% after top Bristol-Myers Squibb holder opposes deal,MarketWatch
Feb-27-19,Top Bristol-Myers shareholder comes out against $74 billion Celgene deal,Reuters
Feb-27-19,[$$] Big Bristol-Myers Shareholder Opposes Celgene Deal,The Wall Street Journal
Feb-27-19,Top Bristol-Myers shareholder comes out against $74 billion Celgene deal,Reuters
Feb-27-19,Top Bristol-Myers shareholder comes out against $74 bln Celgene deal,Reuters
Feb-27-19,Celgene Stock Tumbles After Bristol-Myers Squibb Shareholder Opposes Takeover,Barrons.com
Feb-27-19,Celgene falls 8 percent after Wellington Management says it opposes Bristol-Myers acquisition,CNBC
Feb-27-19,Wellington Management says does not support Bristol-Myers-Celgene deal,Reuters
Feb-27-19,Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You,Motley Fool
Feb-27-19,"Clovis (CLVS) Q4 Earnings Lag Estimates, Rubraca Sales Recover",Zacks
Feb-27-19,Clovis Oncology Inc (CLVS) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-28-19,Starboard joins opposition to Bristol-Myers' $74 billion Celgene deal,Reuters
Feb-28-19,US STOCKS-U.S. stocks edge downward as Wall St takes a pause,Reuters
Feb-28-19,Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates,Zacks
Feb-28-19,5 Pharmaceutical Stocks With Big Moats and Bridges,Kiplinger
Feb-28-19,US STOCKS-Wall St flat; strong GDP counters Trump-Kim summit failure,Reuters
Feb-28-19,Celgene's stock tumbles after Bristol-Myers shareholders oppose the buyout deal,MarketWatch
Feb-28-19,Starboard Details Opposition to Bristol-Myers Deal for Celgene,The Wall Street Journal
Mar-01-19,Intellia CEO not involved in Starboard's Bristol-Myers board challenge,Reuters
Mar-01-19,"The Bristol-MyersSquibb Deal May No Longer Be a Sure Thing, but It Will Still Likely Happen",Barrons.com
Mar-01-19,Big Money Volatility Trader Targets Bristol-Myers Squibb Stock,Schaeffer's Investment Research
Mar-01-19,"Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices",Zacks
Mar-01-19,"Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended",Zacks
Mar-01-19,"Fridays Vital Data: Square, Southwest Airlines and Celgene",InvestorPlace
Mar-01-19,"Bristol-Myers tries to salvage $74 billion deal with Celgene. Meets with investors in New York, Boston",CNBC
Mar-04-19,"Bristol-Myers Squibb's $74B deal for Celgene criticized, called risky",American City Business Journals
Mar-05-19,"Top Analyst Reports for Boeing, Abbott & PayPal",Zacks
Mar-05-19,3 Best Biotech Bargain Stocks on the Market Right Now,Motley Fool
Mar-05-19,Bristol-Myers Squibb to Take Part in the Cowen and Company 39th Annual Health Care Conference,Business Wire
Mar-06-19,Bristol-Myers Squibb to Take Part in the Barclays 2019 Global Healthcare Conference,Business Wire
Mar-06-19,Bristol Slides As Drug Giant Defends Its Looming Celgene Takeover,Investor's Business Daily
Mar-06-19,"Top Analyst Reports for Boeing, Abbott & PayPal",Zacks
Mar-06-19,Bristol-Myers defends Celgene bet as investor criticism grows,Reuters
Mar-06-19,Bristol-Myers says Celgene deal is 'best path' as investor opposition mounts,Reuters
Mar-06-19,Why Bristol-Myers Squibb (BMY) is a Great Dividend Stock Right Now,Zacks
Mar-06-19,"Analysis: Positioning to Benefit within Bristol-Myers Squibb, AAR, Central Garden & Pet, Alexion Pharmaceuticals, Tribune Media, and Civitas Solutions  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Mar-06-19,Bristol-Myers urges shareholders in open letter to support $74 billion Celgene deal amid resistance,CNBC
Mar-06-19,Starboard Mails Letter with Important Message to All Bristol-Myers Squibb Stockholders,PR Newswire
Mar-06-19,"Celgene buy best path forward, Bristol-Myers says",Reuters
Mar-06-19,Bristol-Myers Squibb Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding Pending Transaction with Celgene,Business Wire
Mar-07-19,Bristol-Myers Squibb Announces Dividend,Business Wire
Mar-07-19,I Like the Long Side of Bristol-Myers Squibb,TheStreet.com
Mar-08-19,"Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat",Zacks
Mar-08-19,[$$] Why old-school asset managers are copying the activists,Financial Times
Mar-11-19,"Third Point holds Celgene stock, in bet Bristol-Myers deal will close -source",Reuters
Mar-11-19,Here's Why Seres Therapeutics Stock Soared Today,Motley Fool
Mar-11-19,Bayer Submits Application in EU for Prostate Cancer Drug,Zacks
Mar-11-19,Is Bristol-Myers (BMY) a Solid Pick for Value Investors?,Zacks
Mar-12-19,Celgene (CELG) Submits Application for MS Drug in Europe,Zacks
Mar-12-19,Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation,Zacks
Mar-12-19,3 Brand-Name Healthcare Stocks That Haven't Been This Cheap in a Decade,Motley Fool
Mar-12-19,Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies,GlobeNewswire
Mar-13-19,5 Biotech Stocks to Keep an Eye on in 2019,GuruFocus.com
Mar-13-19,"Celgenes Positive Drug Data Bolsters Bristol-Myers Deal, Analyst Says",Barrons.com
Mar-13-19,"A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says",Barrons.com
Mar-14-19,U.S. court rejects Alvogen's patent challenge for Celgene's cancer drug,Reuters
Mar-14-19,U.S. patent court rejects Alvogen's challenge for Celgene's Revlimid,Reuters
Mar-15-19,Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?,Motley Fool
Mar-15-19,Infinity Inks Deal With Roche for Phase II Study of IPI-549,Zacks
Mar-15-19,Merck's Keytruda Gets EU Approval for Difficult Lung Cancer,Zacks
Mar-15-19,"Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&amp;J, AGN &amp; Others",Zacks
Mar-15-19,Some Bristol-Myers Squibb (NYSE:BMY) Shareholders Are Down 25%,Simply Wall St.
Mar-15-19,J&amp;J Seeks Approval for Darzalex in Expanded Patient Group,Zacks
Mar-18-19,Novartis' (NVS) Alcon Acquired PowerVision for $285 Million,Zacks
Mar-19-19,Starboard Is Against the Bristol-Myers and Celgene Deal. Now It Gets Interesting.,Barrons.com
Mar-19-19,"Bristol-Myers Pushes Celgene Deal, Starboard Hits Back, in $74B Takeover Spat",TheStreet.com
Mar-19-19,Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer,Zacks
Mar-19-19,"Jim Cramer Breaks Down Tilray Earnings, Elon Musk's Twitter and Bristol-Myers",TheStreet.com
Mar-19-19,Bristol-Myers Squibb and Starboard Value square off over Celgene deal,American City Business Journals
Mar-19-19,Large-Cap Pharmaceuticals Industry Outlook: A Recovery Ahead?,Zacks
Mar-19-19,Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's Ill-Advised Proposed Acquisition of Celgene,PR Newswire
Mar-19-19,Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene,Business Wire
Mar-20-19,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Mar-20-19,Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study,Zacks
Mar-21-19,Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market,Zacks
Mar-21-19,Bristol-Myers' Celgene Buyout Still Uncertain Amid Opposition,Zacks
Mar-21-19,Proxy Advisors Could Tilt the Scales in the Bristol-Celgene Deal. Watch for Their Calls Next Week.,Barrons.com
Mar-22-19,Why Bristol-Myers Squibb (BMY) is a Great Dividend Stock Right Now,Zacks
Mar-25-19,J&amp;J Files Application for Darzalex Label Expansion in Europe,Zacks
Mar-25-19,"Report: Developing Opportunities within Bristol-Myers Squibb, AutoNation, FirstEnergy, Charles River Laboratories International, Yum! Brands, and AGNC Investment  Future Expectations, Projections Moving into 2019",GlobeNewswire
Mar-25-19,Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Materials,Business Wire
Mar-26-19,Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know,Zacks
Mar-26-19,"Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote",American City Business Journals
Mar-26-19,Celgene (CELG) Submits NDA for MS Drug to FDA for Review,Zacks
Mar-26-19,"Celgene Stock Is Up Because Its FDA Application Is a Good Sign, Analyst Says",Barrons.com
Mar-26-19,FTC focuses on psoriasis franchise for Bristol-Celgene deal review,Reuters
Mar-26-19,FTC focuses on psoriasis franchise for Bristol-Celgene deal review,Reuters
Mar-26-19,FTC seeks more information to review Bristol-Celgene's $74 bln planned merger,Reuters
Mar-26-19,Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal,TheStreet.com
Mar-26-19,"Jim Cramer Gives His Opinion On Bristol-Myers Squibb, Moderna And More",Benzinga
Mar-27-19,5 Cancer-Fighting Stocks to Boost Portfolio Gains,Zacks
Mar-27-19,J&amp;J Files sBLA for Darzalex in Expanded Myeloma Patient Group,Zacks
Mar-28-19,Is Biogen a Beat-Up Bargain? And Is Bristol-Myers' Mega-Merger on the Rocks?,Motley Fool
Mar-28-19,Starboard Mails Letter to All Bristol-Myers Squibb Shareholders,PR Newswire
Mar-28-19,Jefferies' revenue hurt by U.S. govt. shutdown and weak markets in Dec.,Reuters
Mar-29-19,Bristol-Myers Gets ISS Support for Celgene Takeover; Starboard Drops Opposition,TheStreet.com
Mar-29-19,Are the health care stocks flat lining? Here are the beaten down names traders are still buying,CNBC Videos
Mar-29-19,Stock Market Today: Lyft Goes Public,Motley Fool
Mar-29-19,Dow rallies more than 200 points as S&P 500 logs its best quarterly advance since 2009,MarketWatch
Apr-01-19,Celgene Gets Positive CHMP Nod for Revlimid Label Expansion,Zacks
Apr-01-19,Bristol-Myers' (BMY) Acquisition of Celgene Looks Certain,Zacks
Apr-01-19,Bristol-Myers Squibb/Celgene deal opponent backs off its opposition,American City Business Journals
Apr-01-19,Celgene stock downgraded to neutral at UBS,MarketWatch
Apr-01-19,"The Zacks Analyst Blog Highlights: Phillip Morris, Bristol-Myers, Walgreens, Sirius and Total System",Zacks
Apr-01-19,3 Big Pharma Stocks to Add to Your Portfolio This April,Zacks
Apr-01-19,Here's what to expect from the stock market next month,Investopedia
Apr-02-19,Why Celgene's Shares Soared 13.5% in March,Motley Fool
Apr-02-19,Bristol-Myers Squibb Announces Long-Term Survival Results from Pooled Analyses of Opdivo (nivolumab) in Previously-Treated Non-Small Cell Lung Cancer Patients,Business Wire
Apr-03-19,Clovis Posts Data on Rubraca Study for Pancreatic Cancer,Zacks
Apr-05-19,Bill Nygren's 1st Quarter Oakmark Fund Commentary,GuruFocus.com
Apr-05-19,"Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU",Zacks
Apr-05-19,Health Day Checkup of Medical ETFs: 5 Top Picks,Zacks
Apr-08-19,Celgene &amp; Acceleron Submit BLA for Luspatercept to the FDA,Zacks
Apr-08-19,Why the Earnings Surprise Streak Could Continue for Bristol-Myers (BMY),Zacks
Apr-08-19,9 Companies That May Be on Warren Buffett's Takeover List,Investopedia
Apr-08-19,"3 Big Stock Charts for Monday: Bristol-Myers Squibb, Centurylink and Campbell Soup Company",InvestorPlace
Apr-09-19,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Apr-10-19,Here's what to expect from the stock market next month,Investopedia
Apr-10-19,Is AstraZeneca Stock Worth Buying Before Earnings?,InvestorPlace
Apr-10-19,"Bristol-Myers Squibb, JPMorgan Chase, and Other Dividend-Paying Stocks That Could Beat the Market",Barrons.com
Apr-10-19,Starboard eclipses Elliott as most prolific activist hedge fund,Financial Times
Apr-11-19,6 Poorly Performing Stocks in Gurus' Portfolios,GuruFocus.com
Apr-11-19,Bulls bet on one energy name. Plus: where Bristol-Myers may be heading,CNBC Videos
Apr-11-19,Seattle Genetics' Adcetris Progresses Well Amid Competition,Zacks
Apr-11-19,BMY Stock Looks Really Appetizing as the Celgene Merger Approaches,InvestorPlace
Apr-12-19,Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene,CNBC Videos
Apr-12-19,Bristol-Myers says shareholders vote to approve Celgene takeover,Reuters
Apr-12-19,Bristol-Myers Squibb Shareholders Approve Celgene Tie-Up,TheStreet.com
Apr-12-19,Bristol-Myers Squibb Shareholders Approve Celgene Acquisition,Business Wire
Apr-12-19,"Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal",Zacks
Apr-12-19,Bristol-Myers shareholders approve $90bn Celgene takeover,Financial Times
Apr-15-19,52-Week Company Lows,GuruFocus.com
Apr-15-19,Bristol-Myers' Shareholders Vote for Celgene Acquisition,Zacks
Apr-15-19,Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer,Zacks
Apr-16-19,Bristol-Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know,Zacks
Apr-16-19,Watch CNBC's exclusive interview with Starboard Value CEO Jeff Smith,CNBC Videos
Apr-16-19,Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition Closes,Motley Fool
Apr-17-19,Bristol-Myers Squibb Company -- Moody's assigns A2 to Bristol-Myers's exchange notes; under review for downgrade,Moody's
Apr-17-19,Bristol-Myers Squibb Company Announces Commencement of Exchange Offers and Consent Solicitations for Celgene Notes,Business Wire
Apr-17-19,"Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal",Zacks
Apr-18-19,Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth,Zacks
Apr-22-19,52-Week Company Lows,GuruFocus.com
Apr-22-19,Will Bristol-Myers (BMY) Disappoint This Earnings Season?,Zacks
Apr-23-19,19 Surprising Stocks With a History of Earnings Surprises,Kiplinger
Apr-23-19,"You can find plenty of solid stock bargains in this years worst-performing sector, analyst says",MarketWatch
Apr-23-19,Why Is Bristol-Myers Near 52-Week Lows?,InvestorPlace
Apr-23-19,What's in Store for Celgene Corporation (CELG) Q1 Earnings?,Zacks
Apr-23-19,Are You Looking for a High-Growth Dividend Stock? Bristol-Myers Squibb (BMY) Could Be a Great Choice,Zacks
Apr-23-19,Bristol-Myers (BMY) Moves to Buy: Rationale Behind the Upgrade,Zacks
Apr-23-19,Top 5 ROE Stocks to Buy on Better-Than-Expected Q1 Earnings,Zacks
Apr-24-19,Bristol-Myers Squibb Expected to Earn $1.09 a Share,TheStreet.com
Apr-24-19,AbbVie and Bristol-Myers Squibb will report first-quarter earnings on Thursday. Heres what to expect,MarketWatch
Apr-24-19,"You can find plenty of solid stock bargains in this years worst-performing sector, analysts say",MarketWatch
Apr-24-19,Bristol-Myers Squibb Reports Earnings Tomorrow. Heres What to Expect.,Barrons.com
Apr-25-19,These Pharmas Beat First-Quarter Forecasts; But Biosimilars Rankled One,Investor's Business Daily
Apr-25-19,"Bristol-Myers Q1 Earnings Beat, Sales Up on Strong Eliquis",Zacks
Apr-25-19,Bristol-Myers Squibb Co (BMY) Q1 2019 Earnings Call Transcript,Motley Fool
Apr-25-19,Bristol-Myers Squibb Earnings: BMY Stock Pops on Q1 Beat,InvestorPlace
Apr-25-19,Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition Looming,Motley Fool
Apr-25-19,Pfizer Stock Has Positive and Negative Catalysts Going Into Results,InvestorPlace
Apr-25-19,"Bayer (BAYRY) Q1 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Apr-25-19,Bristol-Myers Tops Q1 Earnings Estimate After Winning Celgene Takeover Approval,TheStreet.com
Apr-25-19,Exelixis (EXEL) to Report Q1 Earnings: What's in Store?,Zacks
Apr-25-19,"The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings",Benzinga
Apr-25-19,Bristol-Myers: 1Q Earnings Snapshot,Associated Press
Apr-25-19,"3 Big Stock Charts for Thursday: Discovery, Norfolk Southern and Bristol-Myers Squibb",InvestorPlace
Apr-25-19,Bristol-Myers profit slightly tops Wall Street view on blood thinner sales,Reuters
Apr-25-19,Bristol-Myers profit slightly tops Wall Street view on blood thinner sales,Reuters
Apr-25-19,Bristol-Myers Squibb Reports First Quarter Financial Results,Business Wire
Apr-25-19,Bristol-Myers Squibb Reports Earnings Today. Heres What to Expect.,Barrons.com
Apr-25-19,"Stocks Edge Lower as Growth Concerns Resurface, Offsetting Solid US Earnings",TheStreet.com
Apr-25-19,"Bristol-Myers Squibb Earnings, Revenue Beat in Q1",Investing.com
Apr-25-19,Biocartis Group NV: BIOCARTIS Q1 2019 BUSINESS UPDATE,GlobeNewswire
Apr-26-19,2 Large Drug Manufacturers Release 1st-Quarter Results,GuruFocus.com
Apr-26-19,Edited Transcript of BMY earnings conference call or presentation 25-Apr-19 2:30pm GMT,Thomson Reuters StreetEvents
Apr-26-19,Celgene (CELG) Q1 Earnings Beat Estimates on Revlimid Sales,Zacks
Apr-26-19,3 Reasons Why Growth Investors Shouldn't Overlook Bristol-Myers (BMY),Zacks
Apr-29-19,Celgene's Final Earnings Report?,Motley Fool
Apr-29-19,52-Week Company Lows,GuruFocus.com
Apr-29-19,3 Stocks Peter Lynch Would Love,Motley Fool
Apr-30-19,"Trump, Democratic leaders to meet on drug prices soon -White House",Reuters
Apr-30-19,The 10 Best Health Care Stocks to Buy for 2019,Kiplinger
May-01-19,The top 2 health care names to play for a catch-up: Technician,CNBC Videos
May-01-19,Bristol-Myers Squibb Company Announces Launch of Private Offering of Senior Unsecured Notes,Business Wire
May-01-19,"Top Research Reports for ExxonMobil, Morgan Stanley & Bristol-Myers",Zacks
May-02-19,"Cramer reviews the top activist stories of 2019: eBay, Dollar Tree, Bristol-Myers, and Bed Bath & Beyond",CNBC
May-02-19,Drugmakers lobbying spending at 10-year high as Washington targets soaring prices,MarketWatch
May-02-19,Bristol-Myers Squibb Company -- Moody's assigns A2 to Bristol-Myers's sr. notes; under review for downgrade,Moody's
May-02-19,Exelixis (EXEL) Earnings &amp; Revenues Beat Estimates in Q1,Zacks
May-02-19,"The Zacks Analyst Blog Highlights: FirstEnergy, Synchrony Financial, ExxonMobil, Morgan Stanley and Bristol-Myers",Zacks
May-03-19,"Bristol-Myers Acquisition of Celgene Is a Prescription for Success, One Analyst Says",Barrons.com
May-03-19,Drugmakers lobbying spending at 10-year high as Washington targets soaring prices,MarketWatch
May-03-19,Seattle life sciences industry has strength in numbers despite uncertainty,American City Business Journals
May-07-19,Bristol-Myers Borrows $19 Billion in Year's Biggest Bond Deal,Bloomberg
May-07-19,What Comes After 2019s Biggest Bond Deal? A Big Debt Diet,Bloomberg
May-07-19,Bristol-Myers Squibb Is Selling $19 Billion of Bonds to Buy Celgene,Barrons.com
May-07-19,What's in the Cards for Nektar (NKTR) This Earnings Season?,Zacks
May-07-19,Will Higher Expenses Dent Cronos' (CRON) Earnings in Q1?,Zacks
May-07-19,"Bausch's (BHC) Q1 Earnings Beat Estimates, Revenues Miss",Zacks
May-07-19,Bristol-Myers Squibb nears $19bn debt sale to fund Celgene deal,Financial Times
May-08-19,IBM Gets a Tepid Reception for Its $20 Billion Bond Sale,Barrons.com
May-08-19,"Mallinckrodt (MNK) Beats on Q1 Earnings &amp; Sales, Raises View",Zacks
May-08-19,"Aerie (AERI) Q1 Earnings Beat, Rhopressa Misses Estimates",Zacks
May-08-19,Aduro (ADRO) Q1 Earnings and Revenues Fall Shy of Estimates,Zacks
May-08-19,Array BioPharma (ARRY) Q3 Earnings and Sales Beat Estimates,Zacks
May-08-19,"Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong",Zacks
May-08-19,Infinity (INFI) Earnings and Sales Miss Estimates in Q1,Zacks
May-08-19,"Prothena's (PRTA) Q1 Earnings Beat Estimates, Revenues Miss",Zacks
May-08-19,5 ROE Stocks to Profit as Trade Woes Shake Equity Markets,Zacks
May-08-19,5 Stocks With Upgraded Broker Ratings Worth Betting on Now,Zacks
May-08-19,"Market Morning: Mylan Massacre, Futures Dither, Meatless McDonalds, Uber Drivers Bash Greed, Want More Money",Market Exclusive
May-08-19,Bristol-Myers Squibb Company Prices $19 Billion of Senior Unsecured Notes,Business Wire
May-08-19,Bet on Top Stocks With Rising P/E to Enjoy Solid Gains,Zacks
May-08-19,Should Investors Worry About Corporate Debt? It Depends on Who You Ask.,Barrons.com
May-09-19,"Nektar (NKTR) Q1 Earnings &amp; Revenues Beat, Decline Y/Y",Zacks
May-09-19,Drugmakers lobbying spending at 10-year high as Washington targets soaring prices,MarketWatch
May-09-19,"Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems",Zacks
May-09-19,Bristol-Myers Squibb's Opdivo Stumbles In Late-Stage Brain Cancer Study,Benzinga
May-09-19,Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your Portfolio,Zacks
May-09-19,Bristol-Myers' Opdivo fails late-stage brain cancer trial,Reuters
May-09-19,Bristol-Myers Squibb Announces Phase 3 CheckMate -498 Study Did Not Meet Primary Endpoint of Overall Survival with Opdivo (nivolumab) Plus Radiation in Patients with Newly Diagnosed MGMT-Unmethylated Glioblastoma Multiforme,Business Wire
May-10-19,AVEO Pharmaceuticals (AVEO) Q1 Earnings &amp; Revenues Miss Mark,Zacks
May-10-19,Endo (ENDP) Q1 Earnings &amp; Revenues Beat Estimates,Zacks
May-10-19,Can Bristol-Myers Squibb Company's (NYSE:BMY) ROE Continue To Surpass The Industry Average?,Simply Wall St.
May-13-19,Why Bristol-Myers Squibb's $19 Billion Debt Issuance to Buy Celgene Makes Sense,GuruFocus.com
May-13-19,Buy These 5 Stocks With Impressive Sales Growth Right Away,Zacks
May-13-19,Bristol-Myers (BMY) is an Incredible Growth Stock: 3 Reasons Why,Zacks
May-14-19,Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competition,CNBC
May-14-19,"These Sleepy Stocks Have Done Nothing, But May Wake Up",GuruFocus.com
May-14-19,"Zacks.com featured highlights include: BlackRock, Northrop, Progressive, Interpublic Group and Bristol-Myers",Zacks
May-15-19,Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer,Zacks
May-16-19,Bristol-Myers Squibb to Present New Data on 20 Types of Cancer from Across its Oncology Portfolio at ASCO and EHA 2019,Business Wire
May-16-19,Bristol-Myers Squibb: A Long Idea for Aggressive Traders Only,TheStreet.com
May-16-19,Biocartis Group NV: Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference,GlobeNewswire
May-17-19,Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL,Zacks
May-17-19,"Celgene Gets EC Nod for Label Expansion of Revlimid, Imnovid",Zacks
May-20-19,4 New Stock Picks From Seth Klarman,GuruFocus.com
May-20-19,"Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines",Benzinga
May-20-19,Drugmakers lobbying spending at 10-year high as Washington targets soaring prices,MarketWatch
May-20-19,Bristol-Myers Stock Is Falling Because the Celgene Merger May Not Make Sense,Barrons.com
May-21-19,Merck agrees $1bn deal to buy biopharmaceutical company Peloton,Financial Times
May-22-19,Array BioPharma Gains on Colorectal Cancer Study Success,Zacks
May-22-19,Mallinckrodt (MNK) Down After Filing Suit Against HHS and CMS,Zacks
May-22-19,Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond,Benzinga
May-22-19,Merck to Buy Private Cancer Drugmaker Peloton Therapeutics,Zacks
May-22-19,"Bristol-Myers Stock Continues to Slump, but Director Ted Samuels Is Buying Up Shares",Barrons.com
May-23-19,Synlogic (SYBX) Enters Cancer Collaboration with Roche,Zacks
May-23-19,"Novartis Reports Data on Asthma Drug, Update from Annual Meet",Zacks
May-24-19,"Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates",Zacks
May-24-19,5 ROE Stocks to Buy as Trade Concerns Spur Market Volatility,Zacks
May-24-19,Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes,Business Wire
May-28-19,This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy,Motley Fool
May-29-19,5 Pharmaceutical Stocks With Big Moats and Bridges,Kiplinger
May-29-19,Bristol-Myers Impending Acquisition of Celgene Leaves Analysts Skeptical,Barrons.com
May-29-19,Have Insiders Been Buying Bristol-Myers Squibb Company (NYSE:BMY) Shares?,Simply Wall St.
May-29-19,BMY or NVO: Which Is the Better Value Stock Right Now?,Zacks
May-29-19,Celgene's Revlimid-Rituximab Combo Gets FDA Nod for Lymphoma,Zacks
May-30-19,Bayer's Aliqopa Gets Breakthrough Therapy Status by FDA,Zacks
May-31-19,Bristol-Myers Squibb (BMY) Stock Moves -1.11%: What You Should Know,Zacks
May-31-19,Roche (RHHBY) Up 6.3% YTD on Strong Demand for New Drugs,Zacks
May-31-19,Novartis (NVS) Reports Positive Phase III Data on Asthma Drug,Zacks
Jun-03-19,Why Cancer-Fighting Stocks &amp; ETFs Are Soaring,Zacks
Jun-03-19,Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with the Combination of Opdivo (nivolumab) and Yervoy (ipilimumab),Business Wire
Jun-03-19,52-Week Company Lows,GuruFocus.com
Jun-03-19,Novartis (NVS) Announces Various Data Presentations at ASCO,Zacks
Jun-03-19,AstraZeneca's Imfinzi Shows Long-Term Benefits in Lung Cancer,Zacks
Jun-03-19,Roche Presents Positive Data on Xolair &amp; Updates From ASCO,Zacks
Jun-03-19,Merck's Keytruda Improves 5-Year Survival in Lung Cancer,Zacks
Jun-03-19,Gilead Presents Data on CAR T Cell Therapy Candidate at ASCO,Zacks
Jun-03-19,Bristol-Myers Squibb Announces First Presentation of Results for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combination in Advanced Hepatocellular Carcinoma at ASCO 2019,Business Wire
Jun-04-19,Bristol-Myers Squibb to Take Part in Goldman Sachs 40th Annual Global Healthcare Conference,Business Wire
Jun-04-19,Here's Another Checkmark For Bristol's Looming Celgene Takeover,Investor's Business Daily
Jun-04-19,Aduro Stock Crashes After ASCO Updates on Cancer Candidate,Zacks
Jun-04-19,Amgen's KRAS Inhibitor Shows Impressive Anti-Tumor Activity,Zacks
Jun-04-19,Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication,Zacks
Jun-04-19,Bristol-Myers (BMY) Presents Multiple Data on Opdivo at ASCO,Zacks
Jun-04-19,"China to Audit Sanofi, Bristol-Myers in Drugmaker Accounts Probe",Bloomberg
Jun-05-19,The Celgene Merger Looks Secure  So Why Is Bristol Under Pressure?,Investor's Business Daily
Jun-05-19,Cancer-Fighting Stocks &amp; ETF: What You Need to Know,Zacks
Jun-05-19,Hedge Funds Have Never Been This Bullish On Bristol Myers Squibb Company (BMY),Insider Monkey
Jun-05-19,Merger uncertainty and impending trials for Bristol-Myers leave investors in limbo,MarketWatch
Jun-05-19,Bristol-Myers Is Getting Bigger. Investors Arent Impressed.,Barrons.com
Jun-05-19,Celgene (CELG) Presents Data on Pipeline Candidates at ASCO,Zacks
Jun-05-19,Bristol-Myers Squibb Announces Post-Closing Leadership Team,Business Wire
Jun-06-19,Bristol-Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know,Zacks
Jun-06-19,Celgene &amp; Acceleron's BLA for Luspatercept Accepted by FDA,Zacks
Jun-06-19,Mallinckrodt Down After Agreement with DOJ for Litigation,Zacks
Jun-06-19,Was ASCO Quieter for Big Drug/Biotech Stocks This Year?,Zacks
Jun-06-19,"Bristol-Myers Squibb to Announce Results for Second Quarter 2019 on July 25, 2019",Business Wire
